Nancy Cordes

Ask VT AI
View News Summary
  • BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
  • Cardinal Health beats Q1 estimates, raises guidance, and sees strong performance in the U.S. drug distribution market.
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
  • Cardinal Health beats Q1 estimates, raises guidance, and sees strong performance in the U.S. drug distribution market.
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Nancy Cordes